Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
about
Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes.Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.Phosphorylated neurofilament heavy: A potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
P2860
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
description
im März 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2014
@uk
name
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@en
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@nl
type
label
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@en
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@nl
prefLabel
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@en
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@nl
P2093
P2860
P50
P356
P1476
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
@en
P2093
A. McMichael
A. Van der Walt
A. W. Purcell
A.-L. Ponsonby
B. V. Taylor
C. Chapman
D. R. Morris
D. Williams
F. Pearson
P2860
P304
P356
10.1136/JNNP-2013-306789
P407
P577
2014-03-17T00:00:00Z